Korea's diabetes drug Envlo to enter $1.54 B market in Brazil and Mexico

South Korean firm Daewoong Pharmaceutical has announced the launching of their national new drug #36, 'Envlo (ingredient...

March 1, 2023 | Wednesday | News
Taiwan approves Ono Pharma's non-small cell lung cancer drug with chemotherapy

Japanese firm Ono Pharmaceutical has received the approval of Opdivo (nivolumab) Intravenous Infusion, a human anti-hu...

February 24, 2023 | Friday | News
South Australian Government takes new initiatives to develop biomanufacturing sector

Biomanufacturing sector will be given a boost by the South Australian Government’s announcement of new initiatives...

February 22, 2023 | Wednesday | News
Japanese pharma firm Eisai dissolves joint venture with Italy's Bracco Imaging

Bracco Imaging S.p.A. (Headquartered in Milan, Italy) and Japan based pharmaceutical firm Eisai Co. have announced that ...

February 21, 2023 | Tuesday | News
Capricor Therapeutics inks $100 M deal with Nippon Shinyaku for DMD treatment in Japan

US-based biotech firm Capricor Therapeutics has entered into a partnership with Nippon Shinyaku Co., a Japanese pharmace...

February 20, 2023 | Monday | News
Taiwan's Formosa Pharma inks agreement with US-based Eyenovia for new ophthalmic therapies

Taiwan-based Formosa Pharmaceuticals has entered into a collaboration agreement with US-based Eyenovia, Inc. for the dev...

February 17, 2023 | Friday | News
Eli Lilly ensures patient access to high-quality affordable insulin in Bangladesh

American pharmaceutical firm Eli Lilly and Company will supply its active pharmaceutical ingredient (API) for human...

February 15, 2023 | Wednesday | News
Astellas Pharma announces change of President and CEO

Astellas Pharma Inc. has approved changes to its Representative Director, President and Chief Executive Officer (CEO) an...

February 8, 2023 | Wednesday | News
Zhongchao Inc. announces introduction of Indian anti-influenza drugs in China

Zhongchao Inc. has obtained the general distribution rights in Mainland China for anti-influenza drug from Indian pharma...

February 8, 2023 | Wednesday | News
VALUE is the Trending Word of 2023

The last two years saw a significant leap toward patient-centricity in the pharmaceutical space. In 2023, that trend wil...

February 6, 2023 | Monday | Opinion
Taiwan-based Lotus Pharma launches drug for multiple myeloma in Brazilian market

Taiwan's Lotus Pharmaceutical has announced that together with Adalvo, the company has partnered with Eurofarma, to laun...

February 6, 2023 | Monday | News
Japanese pharma firm Shionogi launches anti-bacterial drug in Denmark

Japan headquartered pharmaceutical company Shionogi & Co. and its European subsidiary, Shionogi B.V. have announced ...

February 2, 2023 | Thursday | News
Singapore offers unique insulating nanomaterial for pharma cold chain management

KrossLinker, a Singapore-based energy-efficiency-focused deep-tech advanced material startup, is designing and developin...

February 2, 2023 | Thursday | News
China-based startup CARsgen partners with Roche for gastric cancer treatment

CARsgen Therapeutics Holdings, a biopharmaceutical startup based in the US and China, has announced collaboration agreem...

February 2, 2023 | Thursday | News
Japan-based Daiichi Sankyo announces new President and COO

Daiichi Sankyo Company has announced the appointment of a new President & Chief Operating Officer (COO) effect...

February 1, 2023 | Wednesday | News
Daewoong inks $336 M deal with CS Pharma for Idiopathic Pulmonary Fibrosis treatment in China

South Korea's Daewoong Pharmaceutical has secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based m...

February 1, 2023 | Wednesday | News
Japan's Ono Pharma acquires multiple oncology programmes from US-based KSQ Therapeutics

Japan-headquartered Ono Pharmaceutical has entered an agreement with US-based KSQ Therapeutics, a clinical-stage biotech...

January 30, 2023 | Monday | News
SN BioScience, Boryeong ink licensing agreement of first generic of anti-cancer drug Abraxane in Korea

Biotech startup SN BioScience and pharma major Boryeong have signed a domestic manufacturing technology transfer an...

January 30, 2023 | Monday | News
Pfizer launches new initiative to improve atrial fibrillation health literacy in Malaysia

Pfizer Malaysia has launched the new Atrial Fibrillation (AF) awareness website, www.afjourney.com.my, together wit...

January 27, 2023 | Friday | News
New Zealand approves new therapy to treat rare gastrointestinal stromal tumour

Specialised Therapeutics Asia (ST), based in Singapore, has announced that a new therapy to treat rare gastroi...

January 24, 2023 | Tuesday | News
Sandoz to acquire rights of antifungal agent Mycamine from Japanese firm Astellas

Japan-headquartered Astellas Pharma has entered into an Asset Purchase Agreement, under which Astellas will transfer the...

January 24, 2023 | Tuesday | News
Mankind Pharma invests in UK-based Actimed for cancer cachexia treatment

India-based Mankind Pharma has invested in a clinical stage specialty pharmaceutical company, Actimed Therapeutics, UK, ...

January 23, 2023 | Monday | News
SK Bioscience accelerates global growth strategy by picking talent from Big Pharma

South Korea-based SK bioscience has announced that Richard Kensinger, PhD (Left), former Director and Head of Drug Subst...

January 23, 2023 | Monday | News
Takeda inks oncology deal worth $730 M with Hutchmed to improve cancer treatment outside China

Japanese pharmaceutical firm Takeda has entered into an exclusive licensing agreement with Hutchmed (China) for the furt...

January 23, 2023 | Monday | News
Hong Kong Science and Technology Parks Corp inks strategic collaboration with Roche

Hong Kong Science and Technology Parks (HKSTP) Corporation has announced a strategic collaboration with Roche, one of th...

January 19, 2023 | Thursday | News